ArticleContraception2025
Use of PROMIS Global-10 to measure changes in health-related quality of life among contraceptive initiators: A feasibility study.
Article in Contraception, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
objectivesThis study aimed to assess the feasibility of recruiting initiators of combined oral contraceptives (COC) or the levonorgestrel intrauterine device (LNG-IUD) and using Patient-Reported Outcomes Measurement Information System (PROMIS) Global-10 to compare the change in health-related quality of life (HRQOL) between baseline and 6 months. STUDY
designWe recruited patients aged 18 to 45 years initiating COC or LNG-IUD at a single academic medical center. We also enrolled patients using a coitally dependent or no contraceptive method (hormonal contraception nonusers) for comparison. Participants completed PROMIS Global-10 at baseline and 6 months. PROMIS Global-10 measures physical and mental health quality of life, with higher scores indicating better health. We calculated the change in t scores from baseline to 6 months using appropriate nonparametric tests.
resultsWe enrolled 150 participants (50 per group) over a 12-month period. Of these, 39 (78%) COC, 44 (88%) LNG-IUD, and 43 (86%) hormonal contraception nonusers completed 6 months of follow-up. We did not observe a significant change in t-scores in paired-sample analyses (physical: median 0.0, interquartile range: -3.1, 3.8, p = 0.35; mental: median 0.1, interquartile range: -4.3, 4.7, p = 0.78) between baseline and 6 months for COC or LNG-IUD users. T scores were similar between the three groups at baseline (physical: p = 0.32; mental: p = 0.20) and 6 months (physical: p = 0.20; mental: p = 0.12).
conclusionsIn our setting, recruitment of COC or LNG-IUD initiators was slower than anticipated. We did not observe a difference in physical and mental HRQOL among patients initiating COC and LNG-IUD at 6 months compared to baseline, nor compared to patients not initiating hormonal contraception, using the PROMIS Global-10. IMPLICATIONS: Using PROMIS Global-10 to measure HRQOL, we did not observe significant changes in HRQOL in the 6 months after starting LNG-IUDs or COC compared to baseline and to people not using hormonal contraception.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.